Back
Arcturus Therapeutics Holdings, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$8.02
Seasonality Move:
31.34%
7 Day Trial
ALL ACCESS PASS
$
7
Arcturus Therapeutics Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 2.5% based on the past 12 years of stock performance.
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Arcturus Therapeutics Holdings, Inc. Stock Undervalued?The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $8.03. The Score for ARCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 2.5% based on the past 12 years of stock performance.
Arcturus Therapeutics Holdings, Inc. Stock Rating
Sell
47
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. overpriced?
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Arcturus Therapeutics Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
24.17
52-Week Low:
5.85
Prediction Charts
Market Cap:
233.2M
Price in USD:
8.03
Volume:
504.8K
Beta:
2.48
Technical Analysis
SMA50:
7.39
SMA100:
7.17
SMA200:
11.49
52-Wk Change:
-21.27%
Stock Predictions
-
Is Arcturus Therapeutics Holdings, Inc. stock public?Yes, Arcturus Therapeutics Holdings, Inc. is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings, Inc. stock quote today?The Arcturus Therapeutics Holdings, Inc. stock price is 8.03 USD today.
-
How to buy Arcturus Therapeutics Holdings, Inc. stock online?You can buy Arcturus Therapeutics Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 6.83 | 6.63 | 6.83 | 6.50 |
| Mar-17 | 6.62 | 6.39 | 6.68 | 6.36 |
| Mar-18 | 6.56 | 6.55 | 6.70 | 6.39 |
| Mar-19 | 6.42 | 6.72 | 6.84 | 6.40 |
| Mar-20 | 6.75 | 6.63 | 6.84 | 6.54 |
| Mar-23 | 6.77 | 6.87 | 6.96 | 6.64 |
| Mar-24 | 6.74 | 6.65 | 6.77 | 6.60 |
| Mar-25 | 6.81 | 7.06 | 7.17 | 6.80 |
| Mar-26 | 7.00 | 7.08 | 7.45 | 6.98 |
| Mar-27 | 7.08 | 6.76 | 7.21 | 6.58 |
| Mar-30 | 7.00 | 6.90 | 7.16 | 6.77 |
| Mar-31 | 7.29 | 7.72 | 7.78 | 7.10 |
| Apr-1 | 7.90 | 7.85 | 8.18 | 7.82 |
| Apr-2 | 7.52 | 8.03 | 8.27 | 7.52 |
Arcturus Therapeutics Holdings, Inc. Earnings
Arcturus Therapeutics Holdings, Inc. Earnings Report: Per Share Arcturus Therapeutics Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings, Inc. Forecast Revenue Growth
Arcturus Therapeutics Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.91 per share, and a decrease next year of $0.18 per share.
* Arcturus Therapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.